166 related articles for article (PubMed ID: 17458165)
1. The development and future of oligonucleotide-based therapies for cervical cancer.
Gu W; Putral LN; Irving A; McMillan NA
Curr Opin Mol Ther; 2007 Apr; 9(2):126-31. PubMed ID: 17458165
[TBL] [Abstract][Full Text] [Related]
2. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.
Putral LN; Bywater MJ; Gu W; Saunders NA; Gabrielli BG; Leggatt GR; McMillan NA
Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770
[TBL] [Abstract][Full Text] [Related]
3. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
[TBL] [Abstract][Full Text] [Related]
4. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
[TBL] [Abstract][Full Text] [Related]
5. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
6. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
7. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
Jonson AL; Rogers LM; Ramakrishnan S; Downs LS
Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502
[TBL] [Abstract][Full Text] [Related]
8. siRNA-based approaches in cancer therapy.
Devi GR
Cancer Gene Ther; 2006 Sep; 13(9):819-29. PubMed ID: 16424918
[TBL] [Abstract][Full Text] [Related]
9. siRNA delivery systems for cancer treatment.
Oh YK; Park TG
Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
[TBL] [Abstract][Full Text] [Related]
10. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer.
Yamato K; Yamada T; Kizaki M; Ui-Tei K; Natori Y; Fujino M; Nishihara T; Ikeda Y; Nasu Y; Saigo K; Yoshinouchi M
Cancer Gene Ther; 2008 Mar; 15(3):140-53. PubMed ID: 18157144
[TBL] [Abstract][Full Text] [Related]
11. siRNA and shRNA as anticancer agents in a cervical cancer model.
Gu W; Putral L; McMillan N
Methods Mol Biol; 2008; 442():159-72. PubMed ID: 18369785
[TBL] [Abstract][Full Text] [Related]
12. Molecular approaches to cervical cancer therapy.
Alvarez-Salas LM; DiPaolo JA
Curr Drug Discov Technol; 2007 Oct; 4(3):208-19. PubMed ID: 17986003
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
Li SD; Huang L
Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
[TBL] [Abstract][Full Text] [Related]
14. Antisense inhibitors, ribozymes, and siRNAs.
Thompson AJ; Patel K
Clin Liver Dis; 2009 Aug; 13(3):375-90. PubMed ID: 19628155
[TBL] [Abstract][Full Text] [Related]
15. Commercial potential of RNAi.
Jain KK
Mol Biosyst; 2006 Nov; 2(11):523-6. PubMed ID: 17216033
[TBL] [Abstract][Full Text] [Related]
16. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
17. Effect of combined antisense oligodeoxynucleotides directed against the human papillomavirus type 16 on cervical carcinoma cells.
Márquez-Gutiérrez MA; Benítez-Hess ML; DiPaolo JA; Alvarez-Salas LM
Arch Med Res; 2007 Oct; 38(7):730-8. PubMed ID: 17845891
[TBL] [Abstract][Full Text] [Related]
18. Oral delivery of siRNA and antisense oligonucleotides.
Akhtar S
J Drug Target; 2009 Aug; 17(7):491-5. PubMed ID: 19530907
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
Yugawa T; Kiyono T
Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
[TBL] [Abstract][Full Text] [Related]
20. Antisense applications for biological control.
Pan WH; Clawson GA
J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
